Last reviewed · How we verify
salt solution without 0.15% HA
salt solution without 0.15% HA is a Small molecule drug developed by Chang Gung Memorial Hospital. It is currently FDA-approved. Also known as: AIM Artificial Tears.
A salt solution without 0.15% hyaluronic acid (HA) is a small molecule used in clinical trials to study its effects on dry eye disease. It is compared to a preservative-free 0.15% HA solution in these trials.
At a glance
| Generic name | salt solution without 0.15% HA |
|---|---|
| Also known as | AIM Artificial Tears |
| Sponsor | Chang Gung Memorial Hospital |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Effect of Preservative-free Low-dose Hyaluronic Acid-containing Salt Solution on Dry Eye Disease (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- salt solution without 0.15% HA CI brief — competitive landscape report
- salt solution without 0.15% HA updates RSS · CI watch RSS
- Chang Gung Memorial Hospital portfolio CI
Frequently asked questions about salt solution without 0.15% HA
What is salt solution without 0.15% HA?
Who makes salt solution without 0.15% HA?
Is salt solution without 0.15% HA also known as anything else?
What development phase is salt solution without 0.15% HA in?
Related
- Manufacturer: Chang Gung Memorial Hospital — full pipeline
- Also known as: AIM Artificial Tears
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing